During the past decade, DADO Medical s.r.o. conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "DADO Medical s.r.o." #1 collaborator was "FGK Clinical Research GmbH" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "DADO Medical s.r.o." are "Migraine" (3 trials), "Migraine Headache" (1 trials) and "Peripheral Post-surgical Neuropathic Pain" (1 trials). Many other conditions were trialed in "DADO Medical s.r.o." in a lesser frequency.

Most popular intervention types in "DADO Medical s.r.o." are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "AP-325" (1 trials), "Erenumab" (1 trials), "Erenumab 140mg" (1 trials) and "Erenumab 70 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "DADO Medical s.r.o." are 5 trials for "All" genders.

Currently, there are NaN active trials in "DADO Medical s.r.o.". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in DADO Medical s.r.o., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in DADO Medical s.r.o., 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".